Balser J R, Martinez E A, Winters B D, Perdue P W, Clarke A W, Huang W, Tomaselli G F, Dorman T, Campbell K, Lipsett P, Breslow M J, Rosenfeld B A
Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-7294, USA.
Anesthesiology. 1998 Nov;89(5):1052-9. doi: 10.1097/00000542-199811000-00004.
Postoperative supraventricular tachyarrhythmia is a common complication of surgery. Because chemical cardioversion is often ineffective, ventricular rate control remains a principal goal of therapy. The authors hypothesized that patients with supraventricular tachyarrhythmia after major noncardiac surgery who receive intravenous beta-adrenergic blockade for ventricular rate control would experience conversion to sinus rhythm at a rate that differs from those receiving intravenous calcium channel blockade.
The rate of conversion to sinus rhythm at 2 and 12 h after treatment was examined in 64 cases of postoperative supraventricular tachyarrhythmia. After adenosine administration, patients who remained in supraventricular tachyarrhythmia were prospectively randomized to receive either intravenous diltiazem or intravenous esmolol for ventricular rate control (unblinded). Loading and infusion rates were adjusted to achieve equivalent degrees of ventricular rate control.
Patients were similar with regard to age and Apache III score. Most patients in both groups had atrial fibrillation (esmolol, 79%; diltiazem, 81%), and none experienced stable conversion with adenosine. Patients randomized to receive esmolol experienced a 59% rate of conversion to sinus rhythm within 2 h of treatment, compared with only 33% for patients randomized to receive diltiazem (intention to treat, P = 0.049; odds ratio, 2.9; 95% confidence interval, 1.046 to 7.8). After 12 h of therapy, the number of patients converting to sinus rhythm increased in both groups (esmolol, 85%; diltiazem, 62%), and the rates of conversion no longer differed significantly. Ventricular rates when supraventricular tachyarrhythmia began and after 2 and 12 h of rate control therapy were similar in the two treatment groups. The in-hospital mortality rate and length of stay in the intensive care unit were not significantly influenced by treatment group.
Among adenosine-resistant patients in the intensive care unit with atrial fibrillation after noncardiac surgery, intravenous esmolol produced a more rapid (2-h) conversion to sinus rhythm than did intravenous diltiazem.
术后室上性快速心律失常是手术常见的并发症。由于药物复律往往无效,控制心室率仍是主要治疗目标。作者推测,在接受非心脏大手术后发生室上性快速心律失常且接受静脉β受体阻滞剂控制心室率的患者中,恢复窦性心律的比例与接受静脉钙通道阻滞剂的患者不同。
对64例术后室上性快速心律失常患者治疗后2小时和12小时恢复窦性心律的比例进行了研究。在给予腺苷后,仍处于室上性快速心律失常的患者被前瞻性随机分组,接受静脉地尔硫䓬或静脉艾司洛尔控制心室率(非盲法)。调整负荷量和输注速率以达到同等程度的心室率控制。
患者在年龄和急性生理与慢性健康状况评分系统III(Apache III)评分方面相似。两组大多数患者为心房颤动(艾司洛尔组79%,地尔硫䓬组81%),且无一例通过腺苷实现稳定复律。随机接受艾司洛尔治疗的患者在治疗后2小时内恢复窦性心律的比例为59%,而随机接受地尔硫䓬治疗的患者仅为33%(意向性分析,P = 0.049;优势比,2.9;95%置信区间,1.046至7.8)。治疗12小时后,两组恢复窦性心律的患者数量均增加(艾司洛尔组85%,地尔硫䓬组62%),且恢复比例不再有显著差异。两个治疗组在室上性快速心律失常发作时以及进行2小时和12小时心率控制治疗后的心室率相似。治疗组对院内死亡率和重症监护病房住院时间无显著影响。
在非心脏手术后入住重症监护病房且对腺苷耐药的心房颤动患者中,静脉注射艾司洛尔比静脉注射地尔硫䓬能更快速(2小时内)地恢复窦性心律。